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ABSTRACT
Objectives: To investigate the role of risk assessment
in predicting suicide in patients with schizophrenia
spectrum disorders (SSDs) receiving secondary mental
healthcare. We postulated that risk assessment plays a
limited role in predicting suicide in these patients.
Design: Retrospective case–control study.
Setting: Anonymised electronic mental health record
data from the South London and Maudsley National
Health Service (NHS) Foundation Trust (SLaM)
(London, UK) linked with national mortality data.
Participants: In 242 227 SLaM service users up to
31 December 2013, 635 suicides were identified. 96
(15.1%) had a SSD diagnosis. Those who died before
1 January 2007 (n=25) were removed from the
analyses. Thus, 71 participants with SSD who died
from suicide over the study period (cases) were
compared with 355 controls.
Main outcome measure: Risk of suicide in relation
to risk assessment ratings.
Results: Cases were younger at first contact with
services (mean±SD 34.5±12.6 vs 39.2±15.2) and with
a higher preponderance of males (OR=2.07, 95% CI
1.18 to 3.65, p=0.01) than controls. Also, suicide
occurred within 10 days after last contact with services
in half of cases, with the most common suicide
methods being hanging (14) and jumping (13). Cases
were more likely to have the following ‘risk
assessment’ items previously recorded: suicidal history
(OR=4.42, 95% CI 2.01 to 9.65, p<0.001), use of
violent method (OR=3.37, 95% CI 1.47 to 7.74,
p=0.01), suicidal ideation (OR=3.57, 95% CI 1.40 to
9.07, p=0.01) and recent hospital discharge (OR=2.71,
95% CI 1.17 to 6.28, p=0.04). Multiple regression
models predicted only 21.5% of the suicide outcome
variance.
Conclusions: Predicting suicide in schizophrenia is
highly challenging due to the high prevalence of risk
factors within this diagnostic group irrespective of
outcome, including suicide. Nevertheless, older age at
first contact with mental health services and lack of
suicidal history and suicidal ideation are useful
protective markers indicative of those less likely to end
their own lives.
INTRODUCTION
Suicide is a major public health problem
with nearly one million deaths across the
world per year.1 Suicide rates in the UK have
remained unchanged over the past 5 years.2
Bleuler3 4 stated that ‘suicidal drive is the
most serious of all schizophrenic symptoms’.
The rate of suicide in schizophrenia has
been recently reported to be from 2%5 to
5%6 lifetime risk, which, while lower than
the previously quoted estimate of 10%,7 8
remains unacceptably high, representing the
largest single cause of excess mortality in
schizophrenia.9–11
Strengths and limitations of this study
▪ This study used a large clinical database linked
to national mortality data to investigate the role
of risk assessment in predicting suicide in
patients with schizophrenia spectrum disorder
(SSD) under secondary mental healthcare over a
5-year period. Those patients with SSD who
took their lives over the study period (cases)
were compared with a control group drawn from
the same database (those participants with SSD
who did not die from suicide).
▪ Suicide risk assessment failed to predict most of
suicides, while most of controls were correctly
identified.
▪ Risk assessment appears to be of little relevance
for patients with SSD receiving secondary
mental healthcare who end their lives.
▪ Older age at first contact with mental health ser-
vices and lack of suicidal history and suicidal
ideation emerged as useful protective markers
indicative of those less likely to end their own
lives.
▪ Risk assessment ratings were unavailable for a
number of patients and the risk factors evaluated
by this instrument may have changed from the
time of assessment to death.
Lopez-Morinigo J-D, et al. BMJ Open 2016;6:e011929. doi:10.1136/bmjopen-2016-011929 1
Open Access Research
group.bmj.com on October 11, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Some recognised general suicide risk factors have
been replicated in people with schizophrenia such as
being male, living alone, depression, hopelessness, previ-
ous suicide attempts,12–14 number of previous admis-
sions,14 self-devaluation, agitation and insomnia.13
Interestingly, prior suicidal ideation has been found to
be relatively uncommonly reported in patients with
psychosis who take later their own lives.15 Moreover,
schizophrenia has been linked to specific suicide risk
factors such as poor treatment compliance.12 13 16
Therefore, certain aspects of insight associated with
compliance17 may prevent patients with psychosis from
ending their lives,18 and this is supported by a recent
12-month follow-up first-episode study.19
With regard to suicide method, patients with schizo-
phrenia have been reported to frequently use violent
suicide methods, particularly jumping from a height or
in front of a train.5 20 21 This has implications for suicide
prevention as restricting access to methods has been
demonstrated to reduce suicide rates at a population
level.21–24
Over the past two decades, the UK Department of
Health has aimed to reduce suicides at a national
level.25 In keeping with this, structured clinical risk
assessments were strongly recommended by the UK
National Institute for Health and Care Excellence
(NICE) guidelines in 200426 and widely used. However,
recent reviews of the NICE guidelines have voiced con-
cerns about the limited role of risk assessment tools and
scales in the clinical management of the patients.27
Moreover, a recent meta-analysis showed that risk scales
are of little use for predicting repeat self-harm in suicide
attempters.28 However, the extent to which these instru-
ments can predict suicide risk in patients with schizo-
phrenia spectrum disorders (SSDs) receiving secondary
mental healthcare has not been sufficiently examined.29
Moreover, concerns have been voiced regarding the role
of risk assessment in preventing suicide in patients with
schizophrenia.30 Also, it remains poorly understood
what specific factors evaluated by the risk assessment
lead patients with schizophrenia under the care of
mental health services to take their own lives.
We aimed to investigate the role of risk assessment in
predicting suicide in patients with SSDs receiving sec-
ondary mental healthcare. Specifically, risk assessment
ratings were compared between patients with SSD who
died by suicide (cases) and those attending the same
service who did not (controls), while adjusting the ana-
lyses for potential confounders, including sociodemo-
graphic and clinical variables and ‘service use’-related
factors. We postulated that, although previous suicide
attempts and suicidal ideation are common risk factors
among those who go on to end their lives, risk assess-
ment plays a limited role in predicting suicide in
patients with SSD under secondary mental health ser-
vices due to the high prevalence of the classic risk
factors evaluated by these instruments within SSD and
suicide being a very rare outcome.
METHODS
Participants
The sample was derived from the South London and
Maudsley (SLaM) Biomedical Research Centre (BRC)
Case Register. SLaM is a National Health Service (NHS)
Trust which provides secondary mental healthcare to
four boroughs in South-East London (UK): Lambeth,
Southwark, Lewisham and Croydon. Approximately 1.23
million inhabitants reside in this geographic catchment
area, which as a whole was found to be comparable with
other populations of London in terms of age, gender,
education and socioeconomic status distributions.31 32
Full electronic health records have been in use across all
SLaM services since 2006, and in 2007–2008 the Clinical
Record Interactive Search (CRIS) system was built which
renders de-identified copies of records available for
research use with appropriate governance structures.31
CRIS currently accesses data on over 250 000 patients.32
The research ethics approval also covers the pseudony-
mised linkage between CRIS data and those from the
Office for National Statistics (ONS) in January 2014,33
which registers all deaths in the UK and the official
cause of death, including suicide and the method of
suicide according to International Classification of
Diseases (ICD)-10 classification.34
Those patients who had received SLaM care (ie, had
at least one face-to-face contact with a clinical member
of staff) before 31 December 2013, had a primary
ICD-10 diagnosis of SSD (F2-ICD-10 codes) and who
had died by suicide (according to the death certificate)
were included as ‘cases’. Those participants with an
‘undetermined cause of death’ (ICD-10 Y) code over the
period from 1 January 2007 to 31 December 2013 were
considered as cases because in the UK most ‘open ver-
dicts’ are very likely to be suicides.35
In addition, five ‘controls’ were selected per ‘case’.
Specifically, for each case we selected the next five in-
dividuals from the SLaM BRC CRIS who received a
primary diagnosis of SSD, had their first face-to-face
contact with a SLaM member of the staff after the date of
first contact with services of the index case and had not
ended their lives by the end of the study period. The con-
trols were unmatched for demographic or clinical vari-
ables to allow investigation of between-group differences.
Measures
Risk assessment
‘Full risk assessment’ is a compulsory target across the
Trust when ‘high risk’ is determined from a ‘brief risk
assessment’, which is mandatory for all active cases. All
patients who have been seen by a member of the staff
have a ‘brief risk assessment’ documented, which is a
narrative record of the patient’s risk: (1) to one’s self;
(2) to others and (3) from others. If the patient is
deemed at ‘high’ risk in any of these domains, a ‘full
risk assessment’ needs to be completed and updated
over time, which consists of a structured assessment
taking the form of present/absent tick-boxes enquiring
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about widely recognised risk factors for three major clus-
ters: suicide, violence and self-neglect. Positive responses
can be summed to create total scores, that is, the higher
the score the greater the suicide risk.36 The most recent
full risk assessment was considered for these analyses.
Demographic and clinical variables
Demographic/clinical covariates included year of birth,
gender, ethnicity, marital status, employment status and
ICD-10 diagnosis. In addition, the type of the most recent
antipsychotic and/or antidepressant recorded either at
the time of death or at the end of the study period (31
December 2013), whichever was sooner, were analysed.
Patient legal status under the UK Mental Health Act 1983
(Amended 2007) and being subject to a ‘community
treatment order’ (CTO)37 were considered.
ICD-10 diagnoses34 were reached by consensus by the
treating multidisciplinary team, including input from a
senior consultant psychiatrist. Specifically, those patients
with a diagnosis within the schizophrenia spectrum
(ICD-10 codes: F20-F29) were included.
Suicide method
Suicide method was ascertained using death certificate33
ICD-10 codes34 and the following groups were consid-
ered: poisoning—X64; hanging—X70; drowning—X71;
cutting—X78; jumping (either from high place or in
front of a vehicle)—X80, X81; suicide by unspecified
means—X84 and undetermined cause of death—Y10-34.
Statistical analyses
Cases and controls were compared in the following
respects: (1) demographic and clinical variables using
Student’s t-tests, Mann-Whitney U tests and χ2 tests, as
appropriate; and (2) full risk assessment, where com-
pleted, both individual items (χ2 test, including ORs and
95% CIs) and total scores (Student’s t-test). In addition,
receiver operating characteristic (ROC) curves38 were
plotted to assess the performance, namely sensitivity and
specificity, of risk assessment total scores to predict
suicide in patients with SSD. Also, the prevalence of
suicide in schizophrenia (5%)6 was used to estimate the
positive and negative predictive values.
The above univariate analyses formed the basis for
further multivariable regression models so they were
unadjusted. Next, binary logistic regression models were
built to investigate inter-relationships between the above
variables with regard to suicide. Statistically significant
variables from the above univariate analyses were added
to a binary logistic regression model. A final regression
model was conducted with the independent variables that
remained significant. ORs and 95% CIs were calculated.
Specifically, the percentage of variance on the dependent
variable (ie, suicide) explained by each model (through
the Nagelkerke R2), the percentage of individuals cor-
rectly classified across groups (cases and controls) and
the individual contribution of each independent variable
to the model (ORs and 95% CIs) were investigated.
A significance level of 5% (two-tailed) was used for all
the above analyses, which were performed using SPSS
V.21.0 (SPSS, Chicago, Illinois, USA).
RESULTS
In 242 227 SLaM service users up to 31 December 2013,
635 deaths from suicide were identified. Of these, 96
(15.1%) had a SSD diagnosis. Those who died before 1
January 2007 (n=25) were removed from the analyses,
leaving 71 cases who were compared with 355 controls.
Sociodemographic and clinical characteristics of the
whole sample are presented in table 1, including com-
parisons across groups.
Table 1 Demographics and clinical characteristics of the sample and between-groups comparisons
All patients
N=426
Cases N=71
(16.7)
Controls N=355
(83.3) p Value
Mean±SD Mean±SD Mean±SD
Age at first referral (years) 33.9±21.2 30.3±21.1 34.6±21.2 0.12
Age at first contact (years) 38.4±14.9 34.5±12.6 39.2±15.2 0.01
Age at death (years) 44.9±18.0 38.5±13.2 63.2±17.6* <0.001
Social deprivation 31.9±11.3 30.2±12.2 32.3±11.1 0.18
n (%) n (%) n (%) OR (95% CI)
Gender (males) 254 (59.6) 52 (73.2) 202 (56.9) 2.07 (1.18 to 3.65) 0.01
Marital status (unmarried) 387 (90.8) 66 (92.9) 321 (90.4) 1.36 (0.51 to 3.60) 0.65
Unemployed 182 (87.1) 28 (82.3) 154 (88.0) 0.64 (0.24 to 1.72) 0.40
Ethnicity
White 189 (44.4) 33 (46.5) 156 (43.9) 1.17 (0.66 to 1.85) 0.70
Black 165 (38.7) 25 (35.2) 140 (39.4) 0.83 (0.49 to 1.42) 0.59
South-Asian 24 (5.6) 5 (7.0) 19 (5.3) 1.34 (0.48 to 3.71) 0.57
Others 27 (6.3) 4 (5.6) 23 (6.4) 0.86 (0.29 to 2.57) 0.79
First language English 251 (58.9) 40 (56.3) 211 (59.4) 0.88 (0.53 to 1.47) 0.69
*Cases compared with those controls who died from natural causes (n=25).
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Specifically, while age at first referral did not differ
across groups, suicidal cases were significantly younger at
the time of first contact with services than controls (34.5
±12.6 vs 39.2±15.2, t=−2.43, p=0.015). There was a
higher male predominance in cases compared with con-
trols (OR=2.07, 95% CI 1.18 to 3.65, p=0.012). However,
no group differences in marital status, employment,
ethnicity, social deprivation or speaking English as first
language emerged from the analyses.
Service use-related factors
As detailed in table 2, cases were seen by a member of
the staff within a shorter period of time from the first
referral than controls (median 20 vs 133 days, respect-
ively), although this difference did not reach signifi-
cance (p=0.12). Also, cases received significantly shorter
duration of care from the Trust teams (median days
1283 vs 2517, p<0.001).
No significant differences were found between cases
and controls in type of last antipsychotic medication pre-
scribed or use of antidepressants. Also, the percentage
of participants under supervised community treatment
did not vary between groups.
Suicide method
Hanging (14) and jumping (13) were the most common
suicide methods. Twenty-six individuals received an
open verdict (undetermined cause of death), as detailed
in table 3. There were no suicides by firearms.
Risk assessment
As shown in table 4, 31 cases (43.6%) had previously
received at least one full risk assessment completed, and
this was significantly lower than in controls (n=214; 60.3%;
OR=0.51, 95% CI 0.30 to 0.85, p=0.012). Interestingly, we
found a significant time trend in increase of risk assess-
ment completions rates (χ2=20.64, p=0.004). In particular,
the suicide risk assessment completion rates according to
the first year of contact with services were: 34.2% before
2007, 53.0% in 2007, 54.1% in 2008, 51.6% in 2009, 64.3%
in 2010, 62.5% in 2011, 57.1% in 2012 and 100% in 2013.
Also, those participants with a documented risk assessment
had received significantly (p<0.001) longer care
(median=2227 days) than those without risk assessment
(median=1092 days).
Mean±SD total scores were higher in cases than controls:
4.52±2.98 vs 3.19±2.17 (p=0.02), respectively. Individual
items differences are detailed in table 4. The following
items were significantly associated with risk of suicide: ‘sui-
cidal history’ (OR=4.42, 95% CI 2.01 to 9.65, p<0.001),
‘previous use of violent method’ (OR=3.37, 95% CI 1.47 to
7.74, p=0.01), ‘suicidal ideation’ (OR=3.57, 95% CI 1.40 to
9.07, p=0.01) and ‘recent discharge from hospital’
(OR=2.71, 95% CI 1.17 to 6.28, p=0.04).
ROC curve analyses for risk assessment total scores
found the most optimal cut-off point to be 3–4, with a sen-
sitivity of 0.58 and specificity of 0.57. The area under the
curve was 0.63 (95% CI 0.51 to 0.74), which is shown in
figure 1 below. If we assume that the prevalence of suicide
in these patients is 5%,6 the positive predictive value was
0.06, while the negative predictive value was 0.96.
Table 2 Service use-related factors of the sample and between-groups comparisons
Total sample
N=426
Cases N=71
(17.7)
Controls
N=355 (83.3) p Value
Median Median Median
Length from referral to first
contact (days)
77 20 133 0.12
Length of service contact (days) 2255 1283 2517 <0.001
Last face-to-face to death (days) 16* 10 63* 0.04
Last hospital discharge to death
(days)
233* 161 571* 0.25
n (%) n (%) n (%) OR (95% CI)
Antipsychotic
Oral classic 10 (2.3) 2 (2.8) 8 (2.2) 1.15 (0.24 to 5.58) 0.69
Oral atypical 200 (46.9) 38 (53.5) 162 (45.6) 1.27 (0.65 to 2.49) 0.51
Clozapine 24 (5.6) 2 (2.8) 22 (6.2) 0.39 (0.09 to 1.72) 0.27
Depot 80 (18.8) 12 (16.9) 68 (19.1) 0.75 (0.37 to 1.52) 0.49
Antidepressant 76 (17.8) 16 (22.5) 60 (16.9) 1.43 (0.77 to 2.66) 0.31
SCT 18 (4.2) 3 (4.2) 15 (4.2) 1.00
*Comparing those who completed suicide (n=71) with those who died from natural causes (n=25).SCT, supervised community treatment.
Table 3 Suicide method (ICD-10 codes)
N=71
Hanging (X70) 14
Jumping (X81, X81) 13
Poisoning (X60) 4
Drowning (X71) 4
Cutting (X78) 2
Unspecified means (X84) 8
Undetermined (Y10–34) 26
ICD, International Classification of Diseases.
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Multivariable regression models
Binary logistic regression was performed to examine
which variables were associated with suicide. Age at first
contact with services, gender and the above four items
from the risk assessment (namely, suicidal history, previous
use of a violent method, suicidal ideation and recent hos-
pital discharge) were added to the model (see table 5).
However, only age at first presentation (OR=0.94, 95%
CI 0.90 to 0.98, p=0.002), suicidal history (OR=4.07,
95% CI 1.80 to 9.18, p=0.001) and suicidal ideation
(OR=3.06, 95% CI 1.14 to 8.20, p=0.026) remained sig-
nificant. The final model (χ2=29.771, df=3, p<0.001)
explained 21.5% (Nagelkerke R2) of the variance on
suicide and correctly classified 86.5% of the participants,
namely 98.6% of controls and 3.2% of cases (table 6).
DISCUSSION
Principal findings
In a large clinical case register sourced from electronic
mental health records linked to national mortality data,
we identified a population of mental health service users
with SSD who ended their lives and we investigated risk
assessment differences between these individuals (cases)
and controls (those who did not take their lives), while
adjusting the analyses for potential confounders, includ-
ing sociodemographic and clinical variables and service
use-related factors. In line with our hypotheses, young age
at first contact with mental health services, previous
suicide attempts and suicidal ideation were associated
with suicide. Owing to the rarity of the outcome and
limited statistical power, suicide in SSD is not a predictable
occurrence, with only 21.5% of the variance explained by
the final regression model, yet older age at first contact
with mental health services and lack of suicidal history
and suicidal ideation are useful protective markers indica-
tive of those less likely to end their own lives.
Comparison with previous research
Risk assessment
Interestingly, suicidal cases were less likely to have a full
risk assessment documented, which was somewhat contra-
dictory to previous literature.29 However, we found a sig-
nificant time trend in an increase of suicide risk
assessment completion rates over the study years, which
Table 4 Full risk assessment: completion rates, individual items and total scores comparison in cases and controls
Total sample
N=245/426 (57.5%)
Cases
N=31/71 (43.6%)
Controls
N=214/355 (60.3%)
Individual items n (%) n (%) n (%) OR (95% CI) p Value
Suicidal history 69 (28.2) 18 (58.1) 51 (23.8) 4.42 (2.01 to 9.65) <0.001
Violent method 41 (16.7) 11 (35.5) 30 (14.0) 3.37 (1.47 to 7.74) 0.01
Plan to end life 9 (3.7) 3 (9.7) 6 (2.8) 3.71 (0.88 to 15.69) 0.09
Suicidal ideation 27 (11.0) 8 (25.8) 19 (8.9) 3.57 (1.40 to 9.07) 0.01
Hopelessness 26 (10.6) 6 (19.3) 20 (9.3) 2.33 (0.85 to 6.35) 0.11
Distress 71 (29.0) 11 (35.5) 60 (28.0) 1.41 (0.64 to 3.12) 0.40
No control of life 50 (20.4) 10 (32.2) 40 (18.7) 2.07 (0.90 to 4.74) 0.09
Alcohol/drugs misuse 78 (31.8) 14 (45.1) 64 (29.9) 1.93 (0.90 to 4.15) 0.10
Impulsivity 81 (33.1) 11 (35.5) 70 (32.7) 1.13 (0.51 to 2.49) 0.84
Living alone 95 (38.8) 10 (32.2) 85 (39.7) 0.72 (0.32 to 1.61) 0.55
Poor physical health 71 (29.0) 5 (16.1) 66 (30.8) 0.43 (0.16 to 1.17) 0.14
Significant loss 63 (25.7) 9 (29.0) 54 (25.2) 1.21 (0.53 to 2.79) 0.66
Disengagement 91 (37.1) 14 (45.2) 77 (36.0) 1.46 (0.68 to 3.13) 0.33
Recent discharge from
hospital
42 (17.1) 10 (32.2) 32 (15.0) 2.71 (1.17 to 6.28) 0.04
Family history 9 (3.7) 0 (0) 9 (4.2) NA 0.62
Total score (mean±SD) 3.36±2.36 4.52±2.98 3.19±2.17 0.02
NA, not applicable.
Figure 1 Receiving operating characteristic (ROC) curve for
risk assessment total score.
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suggests that this difference may have been due to the
longer care received by controls. Indeed, those patients
with a risk assessment completed had been under the
Trust teams for a longer time than those participants
without risk assessment. Also, a full risk assessment may
have been completed due to concerns raised regarding
other risks such as violence and/or self-neglect.36
Moreover, recording of risk assessment has been reported
to be, to some extent, circular. Specifically, some data from
risk assessments following self-harm are more likely to be
recorded if episodes result in a specialist assessment.39
In line with our hypotheses we replicated the role of sui-
cidal history, suicidal ideation, previous use of a lethal
method5 12 16 40 41 and recent hospital discharge2 40 in
suicide risk. However, no associations of recorded hopeless-
ness, impulsivity, alcohol/drugs misuse, living alone or sig-
nificant losses with suicide were found in line with some
previous literature on suicide and psychosis.42 43 Moreover,
most participants with SSD who ended their lives (cases)
did not have the factors evaluated by the risk assessment
with the exception of ‘suicidal history’. Therefore, suicide
in SSD may represent a challenge to the classic suicide
model,44 particularly regarding the role of hopelessness44 45
and impulsivity44 46 in suicide, although this finding may
be due to the relatively high rates of such factors in SSD
per se therefore making it more difficult to ‘pick them out’
against the background. Furthermore, the classic psycho-
social factors evaluated by suicide risk assessment instru-
ments were found to be more relevant for patients without
SSD who died from suicide.21 This finding is consistent
with a previous comparison study between suicide attemp-
ters with schizophrenia and depression which showed that
attempters with schizophrenia had a lower number of life
events which were also less influential on the attempt.47
Of note, a number of suicides occurred shortly after
having been seen by a member of staff, which is in
keeping with previous studies showing the relative
inability of clinicians to predict and/or prevent immi-
nent suicide risk in individuals with SSD under their
care40 48 49 despite risk assessment.
In addition, the ROC curves showed that overall risk
assessment total scores performed poorly in terms of
sensitivity, specificity and positive predictive value, while
the test had a very high negative predictive value, which
is in full agreement with a recent systematic review of
risk assessment scales for predicting repeat self-harms in
suicide attempters.28 However, at a service level the use
of risk assessment tools in NHS-funded hospitals in
England was associated with a lower incidence of repeat
self-harm at 6 months.50
In summary, although suicidal history, suicidal idea-
tion, previous use of a violent suicide method and
recent hospital discharge were significantly associated
with risk of suicide, the regression models correctly clas-
sified most of controls and just a very small proportion
of cases, which is in line with our hypotheses and a
recent editorial.30
Sociodemographic differences
Those participants with SSD who died by suicide (cases)
had their first contact with mental health services at a
younger age than controls, which also remained signifi-
cant in the multivariable regression models, in line with
previous studies showing an increased suicide risk in early
psychosis,4 although late illness onset reduced suicide risk
in an epidemiological study from Taiwan.50 Regarding
gender, we replicated previous findings from samples of
patients with schizophrenia of higher risk of suicide in
men,12 16 40 41 51 which is also consistent with previous
psychological autopsy studies in both psychotic and some,
but not all, non-psychotic psychiatric populations.52
Interestingly, neither being unemployed nor unmar-
ried was associated with increased suicide risk, consistent
with a previous meta-analysis in this diagnostic group.12
Table 5 Multivariable regression model: suicide as the dependent variable and all those statistically significant independent
variables from the bivariate analyses included
β SE Wald p Value OR 95% CI
Age at first contact −0.064 0.021 8.840 0.003 0.94 0.90 to 0.98
Gender 0.317 0.463 0.470 0.493 1.37 0.55 to 3.41
Suicidal history 1.197 0.558 4.599 0.032 3.31 1.11 to 9.89
Violent method 0.325 0.608 0.285 0.593 1.38 0.42 to 4.55
Suicidal ideation 1.108 0.520 4.539 0.033 3.03 1.09 to 8.39
Recent hospital discharge 0.803 0.481 2.789 0.095 2.23 0.87 to 5.72
Table 6 Final regression model: suicide as the dependent variable and only those statistically significant independent
variables from the above multivariable regression model
β SE Wald p Value OR 95% CI
Age at first contact −0.064 0.021 9.306 0.002 0.94 0.90 to 0.98
Suicidal history 1.403 0.415 11.420 0.001 4.07 1.80 to 9.18
Suicidal ideation 1.118 0.503 4.939 0.026 3.06 1.14 to 8.20
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Also, despite previous literature showing a relationship
between ethnicity and suicide in patients with schizo-
phrenia12 and in the general population,53 we found no
evidence of this. This lack of differences in sociodemo-
graphic characteristics between cases and controls may
have been due to insufficient statistical power. However,
it should be noted that the vast majority of patients with
psychosis living in South-East London tend to be single,
unemployed, socially deprived and of black ethnici-
ties.54 55 Moreover, a previous population-level
community-based survey conducted in South-East
London found poor mental health, low socioeconomic
status and being unmarried to be associated with a
history of previous suicide attempts, while black African
ethnicity was protective.56 Although we failed to replicate
these findings in our sample of patients with schizophre-
nia under secondary mental healthcare who took their
lives, our previous comparison study of participants
under secondary mental healthcare who died by suicide
had reported significantly higher levels of social depriv-
ation in patients with SSD than in those with non-SSD
diagnoses.21 Therefore, there are grounds to consider
that low socioeconomic status, which is strongly linked
with psychosis in our catchment area,54 55 may increase
suicide risk in these patients.
Service use-related factors
Of note, cases tended to have a shorter interval than
controls between the referral and first contact with ser-
vices. This finding is in full agreement with a previous
first-episode psychosis study which showed that suicidal
behaviour preceding first contact with services may
shorten the duration of untreated psychosis via leading
the patient to receive psychiatric attention earlier.57
Also, the duration of care was significantly shorter in
those who died from suicide (cases), which is likely to
have been an artefact due to the survival effect among
controls. We replicated the high risk of suicide in
patients with schizophrenia during the immediate
period after hospitalisation.2 16 40 41 48 A third of sui-
cides occurred in the 6-month period after being dis-
charged from a psychiatric ward, which is of particular
concern in patients with a first-episode psychosis.58
Hence, close monitoring over that period of time should
be strongly recommended.2 14
Despite the well-known antisuicidal properties of cloza-
pine59 60 and some previous recommendations promot-
ing the use of antidepressants41 61 and depot
antipsychotics41 for suicide prevention in schizophrenia,
we found no significant differences between cases and
controls in the use of these pharmacological treatments.
However, our negative results were purely observational
and consistent with previous case–control studies in
schizophrenia,16 51 which all may have had insufficient
statistical power.
Receiving community mental healthcare under restric-
tion in accordance with the UK Mental Health Act 1983
(Amended 2007),37 which is known as a CTO, showed
no association with suicide. These findings seem to be
consistent with the UK National Confidential Inquiry
into Suicide and Homicide report,2 according to which
there were 42 suicides in patients subject to a CTO
between 2009 and 2013 in England. The suicide rate in
CTO patients (2.0 per 1000 CTOs in 2009–2012) was
higher than the suicide rate for all patients (0.09/
1000-year), and this is not unexpected, since one criter-
ion for selection of patients for CTO is risk on
discharge.
Suicide method
Regarding suicide method, we replicated that hanging
and jumping (from a height or in front of a vehicle)
were the most common suicide methods5 16 20 24 40 42 62
in SSD. However, patients with SSD were reported to kill
themselves by taking overdoses in Finland.48 Of note, no
suicides by firearms were identified in our study, which
is in line with previous reports from Europe,4 15 reflect-
ing the restrictions to firearms compared with the USA.
Limiting availability of lethal methods has been
demonstrated to reduce suicide rates at a population
level.22 24 Also, restricting access to suicide hotspots such
as heights through safety barriers23 and railway lines by
installing platform edge doors63 has been reported to
reduce overall suicide rates at such places.64 Hence,
installation of physical barriers on bridges, tall buildings
and railway stations, particularly near psychiatric hospi-
tals given our replication finding concerning the
increased suicide risk after hospitalisation2 16 40 41 48 58
may prevent patients with SSD from suicide.21
Strengths and weaknesses
This study focused on the rare outcome of suicide. By
using a large case register linked to national mortality
data, all those patients with a diagnosis of SSD who were
receiving secondary mental healthcare in our catchment
area and died by suicide over 2007–2013 were included
in the study with the only exception of those who ended
their lives outside the UK. Most patients were followed
up over a prolonged period (median=6.17 years). As
only a tiny proportion of patients living in South-East
London receive private mental healthcare, our sample is
likely to be representative. In addition to risk assessment,
a wide range of demographic and clinical variables,
including service use-related factors, were analysed.
However, our results should be considered in the light
of several limitations. First, the sample was formed of
secondary mental health services users living in
South-East London, an inner urban area, and results
may not generalise to people receiving mental health
input from primary care or those in rural areas. Second,
risk assessment ratings were unavailable for a number of
patients. Also, we can speculate that those patients who
had a risk assessment completed were deemed ‘at high
risk’ by their clinical teams. Hence, the likelihood that
these measures and findings relating to speed of assess-
ment reflect the clinical response to perceived suicidal
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risk rather than potential predictors. In addition,
although just the last risk assessment was considered,
risk factors evaluated by this instrument may have
changed from that point to death. Also, it should be
noted that a wide range of variables have been taken
over a prolonged period of time, which also varies across
the study patients, who ranged from having one single
assessment to several years under secondary mental
healthcare, thus reflecting the real-world nature of our
data. In addition, other non-tested variables such as pre-
morbid personality and premorbid adjustment may have
contributed to suicide in our sample. Finally, our control
recruitment method explained above did not include an
algorithm for randomisation of cases and controls.
CONCLUSIONS
Our findings suggest that the classic suicide risk assess-
ment and prevention approach in secondary mental
healthcare appears to have little relevance for patients
with SSD where many traditional risk factors are preva-
lent across the board. Of note, a high number of these
tragic events occurred shortly after a contact with a
mental health professional, hanging and jumping being
the most common suicide methods. Older age at first
contact with mental health services and lack of suicidal
history and suicidal ideation are helpful markers indica-
tive of those less likely to end their own lives.
Hence, a successful approach for suicide prevention is
likely to require a combination of both population-level
strategies such as restricting access to lethal means22 24
and measures focused on high-risk groups such as
patients with SSD,43 including compliance and engage-
ment improving interventions.17–19
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